Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

L Daniel Kisner


  • Director at Oncternal Therapeutics Inc. (ONCT), 2019-09-16
  • Director at Conatus Pharmaceuticals Inc. (CNAT), 2019-07-01
  • Director at Zynerba Pharmaceuticals Inc. (ZYNE), 2019-06-13
  • Director at Dynavax Technologies Corp (DVAX), 2019-05-31
  • Director at Lpath Inc (LPTN), 2016-12-29
  • Other at Tekmira Pharmaceuticals Corp (TKMR), 2015-03-16
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CNAT $5.75 4,000 Director 7,145 2015-04-08 Filing
DVAX $1.08 10,000 Director 15,000 2013-10-30 Filing